# Pharmacokinetics, CYP450 Drug Interactions, TDM & Toxicology Antidotes

> ADME principles, volume of distribution, bioavailability, zero vs first-order elimination, CYP450 inducers/inhibitors, therapeutic drug monitoring, toxidromes, and antidotes.

- **Canonical URL:** https://flashcards.world/flashcards/sets/883587ff-817e-4f55-a991-77d341691e46/
- **Markdown URL:** https://flashcards.world/flashcards/sets/883587ff-817e-4f55-a991-77d341691e46.md
- **Category:** Top 200 Prescribed Drugs (Brand, Generic, Class & MOA)
- **Level:** advanced
- **Languages:** en → en
- **Total Cards:** 32

## Flashcards (32 Cards)

| # | Front (Term / Prompt) | Back (Definition / Answer) | Example | Multiple-Choice Options |
| :--- | :--- | :--- | :--- | :--- |
| 1 | Lithium, Digoxin, Phenytoin & Theophylline — Classic Therapeutic Reference Ranges | Lithium: 0.6–1.2 mEq/L (acute mania 0.8–1.2; toxicity >1.5). Digoxin: 0.5–0.9 ng/mL in HFrEF (0.8–2.0 in A-fib; toxicity >2.0). Phenytoin: 10–20 mcg/mL total (correct for hypoalbuminemia using the Sheiner-Tozer equation or measure free phenytoin 1–2 mcg/mL). Theophylline: 5–15 mcg/mL (toxicity >20 causes seizures and tachyarrhythmias). |  |  |
| 2 | Iron Overdose (Pediatric Prenatal Vitamin Ingestion) — Stages & Deferoxamine Chelation | Free iron causes corrosive hemorrhagic gastroenteritis (abdominal pain, hematemesis, radiopaque pills on KUB), followed by a deceptive quiescent phase, then severe high anion gap lactic acidosis, shock, hepatic necrosis, and late GI strictures. Treated with whole-bowel irrigation and IV Deferoxamine (chelates free iron into ferrioxamine, turning urine 'vin rosé' pink-red). |  |  |
| 3 | Cocaine Intoxication — Triple Reuptake / Na+ Channel Mechanism & Beta-Blocker Caution | Blocks presynaptic reuptake of dopamine, norepinephrine, and serotonin AND blocks voltage-gated Na+ channels (local anesthetic effect + QRS prolongation at toxic doses). Causes hypertension, tachycardia, coronary vasospasm, and agitation. Treat initially with IV Benzodiazepines (plus nitroglycerin/phentolamine for chest pain/HTN); avoid pure beta-blockers acutely due to concern for unopposed alpha-mediated coronary vasoconstriction. |  |  |
| 4 | Methemoglobinemia — Oxidizing Culprits, 'Chocolate-Brown' Blood & Methylene Blue | Dapsone, benzocaine, lidocaine, and nitrates oxidize hemoglobin iron from ferrous (Fe2+) to ferric (Fe3+), which cannot bind O2 and shifts the O2 dissociation curve to the left. Classic triad: Central cyanosis unresponsive to 100% O2, SpO2 plateauing near 85% despite normal arterial PaO2 ('saturation gap'), and chocolate-brown blood. Treated with IV Methylene Blue (reduced by NADPH methemoglobin reductase to leukomethylene blue, which reduces Fe3+ -> Fe2+; contraindicated in G6PD deficiency—use vitamin C instead). |  |  |
| 5 | Cholinergic Toxidrome (Organophosphates / Nerve Agents) — 'DUMBBELLS' & Atropine + Pralidoxime (2-PAM) | Irreversible phosphorylation of acetylcholinesterase causes muscarinic excess (Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Emesis, Lacrimation, Lethargy, Salivation) plus nicotinic muscle fasciculations and weakness. Atropine competitively blocks muscarinic receptors (titrate until bronchial secretions dry); Pralidoxime (2-PAM) regenerates AChE at both muscarinic and nicotinic sites if given before enzyme 'aging'. |  |  |
| 6 | Malignant Hyperthermia — Pharmacologic Triggers, Ryanodine Receptor Defect & Dantrolene | Autosomal dominant RYR1 mutation triggered by volatile inhalational anesthetics (sevoflurane, isoflurane, desflurane) or succinylcholine. Uncontrolled sarcoplasmic reticulum Ca2+ release causes masseter spasm, generalized rigidity, abrupt rise in end-tidal CO2 (earliest sign!), hyperthermia, rhabdomyolysis, and hyperkalemia. Immediately stop trigger, hyperventilate with 100% O2, and give IV Dantrolene. |  |  |
| 7 | Cyanide Poisoning — Cellular Mechanism, Clinical Clues & Hydroxocobalamin Antidote | Binds ferric iron (Fe3+) in mitochondrial cytochrome c oxidase (Complex IV), halting aerobic oxidative phosphorylation. Causes rapid coma, cardiovascular collapse, 'venous arterialization' (high central venous O2 saturation), and severe lactic acidosis (>10 mmol/L) in house fire victims or nitroprusside infusions. Antidote: Hydroxocobalamin (Cyanokit; binds cyanide to form non-toxic cyanocobalamin/vitamin B12 excreted in urine). |  |  |
| 8 | Volume of Distribution (Vd), Clearance (CL) & Elimination Half-Life (t1/2) — Core Pharmacokinetic Equations | Vd = Amount of drug in body / Plasma concentration (C0); Loading Dose = (Vd x Cp) / F. Maintenance Dose = (CL x Cp x tau) / F. Half-life t1/2 = (0.693 x Vd) / CL. It takes 4 to 5 half-lives for a drug infused at a constant rate to reach ~94–97% steady-state concentration (or be completely eliminated). |  |  |
| 9 | First-Order vs Zero-Order Elimination Kinetics — Classic Zero-Order Drugs ('PEA') | First-order kinetics: A constant FRACTION of drug is eliminated per unit time (rate is proportional to plasma concentration; t1/2 is constant). Zero-order (capacity-limited) kinetics: Enzymatic pathways are saturated, so a constant AMOUNT of drug is eliminated per unit time (concentration drops linearly; t1/2 increases as concentration rises). Classic zero-order drugs: Phenytoin, Ethanol, and Aspirin (at toxic doses). |  |  |
| 10 | Copper Overload (Wilson Disease) — Pathophysiology & Penicillamine / Trientine + Zinc | Autosomal recessive ATP7B mutation impairs biliary copper excretion and ceruloplasmin incorporation, depositing copper in the liver (cirrhosis), basal ganglia (parkinsonism/dysarthria), and Descemet membrane (Kayser-Fleischer rings). Treated with copper chelators (Trientine or D-penicillamine) and oral Zinc (induces intestinal metallothionein to block dietary copper absorption). |  |  |
| 11 | Lead, Mercury & Arsenic (Heavy Metal) Poisoning — Clinical Features & Specific Chelators | Lead inhibits ferrochelatase and ALA dehydratase (microcytic anemia with basophilic stippling, Burton gingival lines, wrist/foot drop, encephalopathy, metaphyseal 'lead lines'); treated with Succimer (oral DMSA), EDTA, + Dimercaprol (BAL) if severe. Arsenic (garlic breath, Aldrich-Mees nail lines, QTc prolongation) and Mercury (neuropsychiatric 'erethism', tremor, ATN) are chelated with Dimercaprol or Succimer. |  |  |
| 12 | Sulfonylurea vs Insulin Overdose — C-Peptide Differentiation & Octreotide Role | Both cause profound hypoglycemia. Sulfonylurea overdose stimulates endogenous beta-cell secretion (elevated insulin AND elevated C-peptide), whereas exogenous insulin overdose suppresses endogenous secretion (elevated insulin with low/undetectable C-peptide). In sulfonylurea overdose, IV dextrose alone triggers further insulin release; add subcutaneous Octreotide to directly suppress pancreatic beta-cell insulin release. |  |  |
| 13 | Local Anesthetic Systemic Toxicity (LAST) — Progression of Symptoms & Lipid Emulsion Rescue | Inadvertent intravascular injection or excessive absorption of bupivacaine/lidocaine presents first with perioral numbness, metallic taste, tinnitus, and agitation, progressing to generalized seizures and refractory ventricular arrhythmias/asystole. Treated with airway support, benzodiazepines for seizures, and immediate 20% Intravenous Lipid Emulsion ('lipid sink'). |  |  |
| 14 | Potent Cytochrome P450 Inducers ('CRAP GPS') — Clinical Consequences on Co-Administered Substrates | Carbamazepine, Rifampin, Alcohol (chronic), Phenytoin, Griseofulvin, Phenobarbital, and St. John's Wort upregulate hepatic CYP450 synthesis over days-to-weeks, accelerating metabolism and causing therapeutic failure of oral contraceptives, warfarin (decreases INR), calcineurin inhibitors, and HIV antiretrovirals. |  |  |
| 15 | Anticholinergic vs Sympathomimetic Toxidromes — Critical Physical Exam Distinctions | Both present with tachycardia, hypertension, hyperthermia, mydriasis, and agitated delirium. Anticholinergic toxicity (diphenhydramine, jimsonweed, TCAs, atropine) causes DRY skin/axillae, absent bowel sounds, and urinary retention ('blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone'); treated with physostigmine (if QRS is normal). Sympathomimetic toxicity (cocaine, amphetamines) causes DIAPHORESIS and active bowel sounds; treated with benzodiazepines. |  |  |
| 16 | P-Glycoprotein (MDR1) Efflux Pump — Physiologic Locations & Important Inhibitors | ATP-dependent efflux transporter located at the intestinal brush border, renal proximal tubule, biliary canaliculi, and blood-brain barrier. Inhibitors (verapamil, diltiazem, amiodarone, quinidine, clarithromycin, cyclosporine) markedly increase serum levels of P-gp substrates such as digoxin, dabigatran, and apixaban. |  |  |
| 17 | Digoxin Toxicity — Clinical Manifestations & Digoxin Immune Fab (Digibind) Indications | Presents with GI distress (anorexia, nausea, vomiting), neurological confusion, xanthopsia (yellow-green visual halos), hyperkalemia (marker of acute toxicity severity), and any arrhythmia except rapidly conducted atrial flutter (classic: atrial tachycardia with AV block or bidirectional VT). Administer Digoxin Immune Fab for life-threatening arrhythmias, hemodynamic instability, serum K+ > 5.0 mEq/L in acute ingestion, or digoxin level > 10–15 ng/mL. |  |  |
| 18 | Opioid Toxidrome — Classic Clinical Triad & Naloxone Administration Pitfalls | Triad: CNS depression (coma), respiratory depression (decreased respiratory rate and tidal volume -> hypercapnic acidosis), and pinpoint pupils (miosis). Treated with IV/IM/intranasal Naloxone (competitive mu-opioid antagonist). Because naloxone's half-life (30–90 min) is shorter than methadone/long-acting opioids, patients require observation for recurrent respiratory depression (renarcotization). |  |  |
| 19 | Carbon Monoxide (CO) Poisoning — Pathophysiology, Pulse Oximetry Trap & Treatment | CO binds hemoglobin with >200x the affinity of O2 (forming carboxyhemoglobin) and shifts the oxygen-hemoglobin dissociation curve to the LEFT, impairing O2 delivery and inhibiting mitochondrial cytochrome c oxidase. Standard pulse oximetry is falsely normal (reads COHb as O2Hb); diagnose with co-oximetry and treat with 100% normobaric oxygen or hyperbaric oxygen (for syncope, coma, myocardial ischemia, pregnancy, or COHb > 25%). |  |  |
| 20 | Valproic Acid Overdose / Hyperammonemic Encephalopathy — Mechanism & L-Carnitine Antidote | Valproate depletes hepatic carnitine stores and inhibits carbamoyl phosphate synthetase I (the rate-limiting enzyme of the urea cycle), causing hyperammonemic encephalopathy (even with normal liver enzymes) and cerebral edema. Treated with L-Carnitine supplementation (and hemodialysis in severe overdose). |  |  |
| 21 | Beta-Blocker vs Calcium Channel Blocker Overdose — Hemodynamic/Glycemic Clues & Antidotes | Both cause severe bradycardia, AV block, and hypotension. Beta-blocker overdose causes HYPOGLYCEMIA and bronchospasm; treated with high-dose IV Glucagon (activates Gs -> increases cAMP independent of beta-1 receptors). CCB overdose causes HYPERGLYCEMIA (blocks pancreatic L-type Ca2+ channels -> inhibits insulin release); treated with IV Calcium, high-dose insulin euglycemic therapy (HIET), and norepinephrine. |  |  |
| 22 | High-Anion Gap Metabolic Acidosis Toxicologies — Classic 'MUDPILES' / 'GOLD MARK' Etiologies | Normal anion gap = Na+ - (Cl- + HCO3-) = 8–12 mEq/L. Elevated AG metabolic acidosis is caused by: Glycols (ethylene/propylene), Oxoproline (chronic acetaminophen), L-Lactate (shock, metformin, cyanide, CO, INH), D-Lactate (short bowel syndrome), Methanol, Aspirin (salicylates), Renal failure (uremia), and Ketoacidosis (diabetic, alcoholic, starvation). |  |  |
| 23 | Potent Cytochrome P450 Inhibitors ('SICKFACES.COM') — Clinical Consequences on Co-Administered Substrates | Sodium valproate, Isoniazid, Cimetidine, Ketoconazole (and other azoles), Fluconazole, Alcohol (acute binge), Ciprofloxacin, Erythromycin/Clarithromycin, Sulfonamides (TMP-SMX), Grapefruit juice, Omeprazole (CYP2C19), and Metronidazole acutely inhibit CYP450, causing toxic accumulation of substrates like warfarin (supratherapeutic INR/bleeding), statins, phenytoin, and theophylline. |  |  |
| 24 | Phase I vs Phase II Hepatic Drug Metabolism & Effect of Aging/Cirrhosis | Phase I reactions (oxidation, reduction, hydrolysis via Cytochrome P450) introduce or unmask polar functional groups and often produce active metabolites; Phase I is lost first in elderly and cirrhotic patients. Phase II reactions (glucuronidation, acetylation, sulfation, glutathione conjugation) conjugate polar groups for renal/biliary excretion and are preserved longer in liver disease. |  |  |
| 25 | Ethanol Withdrawal Progression & Wernicke Encephalopathy Prophylaxis Rule | Minor withdrawal (6–12h: tremor, diaphoresis, anxiety) -> alcoholic hallucinosis (12–24h: visual/tactile hallucinations with intact orientation) -> withdrawal seizures (12–48h) -> Delirium Tremens (48–96h: disorientation, severe autonomic hyperactivity, 5–15% mortality). Treat with symptom-triggered benzodiazepines (CIWA protocol). Always administer IV Thiamine (Vitamin B1) BEFORE or with glucose to prevent precipitating Wernicke encephalopathy (confusion, ophthalmoplegia, ataxia). |  |  |
| 26 | Methanol & Ethylene Glycol (Toxic Alcohol) Poisoning — Lab Gaps, Organ Damage & Fomepizole | Present with an initial elevated osmolar gap followed by a severe high anion gap metabolic acidosis as alcohol dehydrogenase converts methanol -> formic acid (optic nerve toxicity/blindness, putaminal hemorrhage) and ethylene glycol -> glycolic/oxalic acid (calcium oxalate envelope crystals in urine, acute renal failure). Treated immediately with Fomepizole (competitive alcohol dehydrogenase inhibitor) and hemodialysis. |  |  |
| 27 | Vancomycin Therapeutic Drug Monitoring — AUC/MIC vs Trough Targets | Contemporary ASHP/IDSA consensus guidelines recommend targeting a 24-hour AUC/MIC ratio of 400–600 mg*h/L for serious MRSA infections (replacing legacy trough-only targets of 15–20 mcg/mL in bacteremia, endocarditis, osteomyelitis, meningitis, and pneumonia) to maximize efficacy while minimizing nephrotoxicity. |  |  |
| 28 | CYP2D6, CYP2C19, NAT2 & TPMT — High-Yield Pharmacogenomic Polymorphisms | CYP2D6 poor metabolizers fail to activate codeine/tramadol and tamoxifen (whereas ultrarapid metabolizers suffer fatal morphine toxicity from codeine). CYP2C19 poor metabolizers fail to activate clopidogrel (causing stent thrombosis). Slow N-acetyltransferase-2 (NAT2) acetylators develop drug-induced lupus from hydralazine, procainamide, and isoniazid. TPMT or NUDT15 deficiency causes life-threatening myelosuppression from azathioprine and 6-mercaptopurine. |  |  |
| 29 | Isoniazid (INH) Overdose — Mechanism of Refractory Seizures & Pyridoxine (Vitamin B6) Antidote | Acute INH overdose inhibits pyridoxal phosphokinase and depletes active pyridoxal-5'-phosphate (Vitamin B6), the essential cofactor for glutamic acid decarboxylase (which synthesizes GABA from glutamate). Causes status epilepticus refractory to benzodiazepines and severe lactic acidosis; treated with gram-for-gram IV Pyridoxine (Vitamin B6). |  |  |
| 30 | Benzodiazepine Overdose — Clinical Presentation & Why Flumazenil Is Often Contraindicated | Presents with slurred speech, ataxia, and CNS depression with remarkably normal vital signs and minimal respiratory depression (unless co-ingested with ethanol or opioids). Flumazenil (competitive GABAA benzodiazepine site antagonist) is rarely used in unknown or chronic benzodiazepine overdoses because it can precipitate refractory status epilepticus. |  |  |
| 31 | Acetaminophen (APAP) Toxicity — Pathophysiology (NAPQI), Rumack-Matthew Nomogram & N-Acetylcysteine (NAC) | At toxic doses (>7.5–10 g or >150 mg/kg), sulfation and glucuronidation saturate, shunting acetaminophen to CYP2E1 to form hepatotoxic NAPQI, which depletes hepatic glutathione and causes centrilobular hepatic necrosis. Plot a 4-hour serum APAP level on the Rumack-Matthew nomogram; treat with N-acetylcysteine (replenishes glutathione stores and acts as a sulfhydryl donor). |  |  |
| 32 | Anticoagulant Reversal Summary Table — Heparin, Warfarin, Apixaban/Rivaroxaban & Dabigatran | Unfractionated Heparin -> Protamine sulfate (1 mg per 100 units UFH; partially reverses LMWH). Warfarin -> 4-Factor PCC + IV Vitamin K (phytonadione). Apixaban / Rivaroxaban (Factor Xa inhibitors) -> Andexanet alfa (or 4-factor PCC). Dabigatran (Direct thrombin inhibitor) -> Idarucizumab. |  |  |

---
Study this deck interactively with FSRS-6 spaced repetition, audio review, and multiple-choice mode at [Flashcards World](https://flashcards.world/flashcards/sets/883587ff-817e-4f55-a991-77d341691e46/).
